GSK trades at lower price multiples compared to competitors due to weaker pipeline.GSK's revenue growth in 2023 was modest, but it has strong performers in its product mix.GSK needs to demonstrate the...
Source LinkGSK trades at lower price multiples compared to competitors due to weaker pipeline.GSK's revenue growth in 2023 was modest, but it has strong performers in its product mix.GSK needs to demonstrate the...
Source Link
Comments